FDA warns Curaleaf about inflated claims in CBD product marketing
4 years ago
32
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
2:11
WFTX
8 months agoDebris, bacteria in SWFL water after Idalia
297 -
0:42
KMGH
2 years agoBBB warns about travel scams
45 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
44 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
11 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
2:04:50
Fresh and Fit
7 hours agoElijah Schaffer Meets Fresh&Fit
67.9K51 -
LIVE
The Anthony Rogers Show
12 hours agoEpisode 305 - Sloan Bella
1,223 watching -
1:41:08
Glenn Greenwald
9 hours agoRussia-Ukraine War Escalates Amid Nuclear Threats, Israel Was Motive Behind TikTok Ban; PLUS: Batya Ungar-Sargon on New Book | SYSTEM UPDATE #267
52.1K76